Skip to main content

Table 2 Indications and practice of using APRV mode with ARDS patients (n = 1,002)

From: Awareness and practice of airway pressure release ventilation mode in acute respiratory distress syndrome patients among nurses in Saudi Arabia

Variables

Values, n%

Section 1: indication and other strategy to improve oxygenation

 Conditions APRV mode utilization is indicated

  ARDS

672 (67.1%)

  COVID-19

468 (46.7%)

  Pneumonia

362 (36.1%)

  Asthma

176 (17.6%)

  Pulmonary edema

174 (17.4%)

  Obesity-induced hypoventilation syndrome

148 (14.8%)

  COPD

147 (14.7%)

  Sleep apnea syndrome

57 (5.7%)

 Strategy to improve oxygenation when conventional MV fails to improve oxygenation

  Prone positioning

444 (43.8%)

  High-frequency oscillatory ventilation (HFOV)

191 (19.1%)

  Airway pressure release ventilation (APRV)

157 (15.7%)

  Extracorporeal membrane oxygenation (ECMO)

111 (11.1%)

  Inhaled nitric oxide

60 (6.0%)

  Other pulmonary vasodilators

39 (3.9%)

Section 2: initial settings and management

 Initial P-high setting

  Equal to the plateau pressure on conventional ventilator

323 (32.2%)

  At 25 cmH2O

227 (22.6%)

  Equal to the mean airway pressure on conventional ventilator

211 (21.1%)

  2—5 cmH2O above mean airway pressure on conventional ventilator

170 (17.0%)

  To achieve tidal volume of 6 ml/kg/pbw (predicted body weight)

71 (7.1%)

 Initial P-low setting

  Match to PEEP from conventional ventilator

400 (39.9%)

  0 cmH2O

217 (21.7%)

  2—5 cmH2O

237 (23.6%)

  Variable depending upon oxygenation

148 (14.8%)

 Initial T-high setting

  2–3 s

171 (17.1%)

  4–6 s

446 (44.5%)

  Per desired minute ventilation and respiratory rate

260 (25.9%)

  Per inspiratory to expiratory (I:E) ratio

125 (12.5%)

 Initial T-low setting

  Set time (i.e. 0.4–0.8 s)

415 (41.4%)

  Per inspiratory to expiratory (I:E) ratio

265 (26.4%)

  When expiratory flow equals 25 – 49% peak expiratory flow

246 (24.5%)

  When expiratory flow equals 50–75% peak expiratory flow

76 (7.6%)

 Maximum allowed tidal volume

  4–6 ml/kg

540 (53.9%)

  7–8 ml/kg

210 (21.0%)

  9–10 ml/kg

134 (13.4%)

  More than 10 ml/kg

59 (5.9%)

  No limit

59 (5.9%)

 Maximum allowed P-high

  30 cmH2O

123 (12.3%)

  35 cmH2O

475 (47.4%)

  40 cmH2O

324 (32.3%)

  No maximum

80 (8.0%)

 Pressure support utilization during spontaneous breathing

  Yes

588 (58.7%)

  No

414 (41.3%)

Section 3: weaning and discontinuation

 Criteria use to wean P-high

  Reduce P-high gradually in attempt to reach a target of 20 cmH2O

234 (23.3%)

  Reduce P-high gradually in attempt to reach a target of 15 cmH2O

309 (30.8%)

  Reduce P-high gradually in attempt to reach a target of 10 cmH2O

329 (32.8%)

  Reduce P-high gradually in attempt to reach a target of 5 cmH2O

130 (13.0%)

 Criteria use to wean T-high

  Increase T-high gradually in attempt to reach a target of 7 s

252 (25.1%)

  Increase T-high gradually in attempt to reach a target of 10 s

444 (44.3%)

  Increase T-high gradually in attempt to reach a target of 15 s

245 (24.4%)

  Increase T-high gradually in attempt to reach a target of 20 s

61 (6.1%)

 Criteria used to switch ARDS patients to CPAP

  FiO2 ≤ 40%

167 (16.7%)

  T-high ≥ 10 s

148 (14.8%)

  P-high ≤ 10cmH2O

131 (13.1%)

  (FiO2 ≤ 40%, T-high ≥ 10 s and P-high ≤ 10cmH2O)

556 (55.5%)

  1. Data are presented as frequency and percentage
  2. Abbreviations: ARDS Acute respiratory distress syndrome, APRV Airway pressure release ventilation, COVID-19 Coronavirus disease of 2019, COPD Chronic obstructive pulmonary disease, PEEP Positive end-expiratory pressure, CPAP Continuous positive airway pressure